TrialThe American journal of pathology2014

Cerebrospinal fluid α-synuclein predicts cognitive decline in Parkinson disease progression in the DATATOP cohort.

Tessandra Stewart et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.